Press release
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025
Biopharma PEG offers a comprehensive portfolio of over 4,000 PEG derivatives, including monodispersed, polydispersed, and multi-arm PEGs, available in quantities from milligrams to 100 kilograms. Their diverse product line supports critical applications in the biopharmaceutical industry, including:
PEGylation: Enhancing drug efficacy and delivery.
LNP-based drug delivery: Facilitating the development of lipid nanoparticle formulations.
ADC therapy: Providing essential linkers for antibody-drug conjugates.
PROTAC development: Enabling the creation of proteolysis-targeting chimeras.
Hydrogels: Supporting tissue engineering and drug delivery matrices.
Diagnostics: Contributing to advanced diagnostic tools and assays.
"We are excited to connect with the TIDES community and showcase our broad spectrum of PEG derivatives," said Sonia Lee, Head of Business Development at Biopharma PEG. "Our commitment to providing both catalog and custom PEG solutions, manufactured under stringent GMP conditions, ensures that our partners receive the highest quality materials to accelerate their innovative work."
At Booth #913, visitors can:
Explore a Wide Range of Catalog PEGs: Discover readily available products for rapid project initiation
Discuss Custom Synthesis Capabilities: Learn how Biopharma PEG can tailor PEG solutions to meet specific project requirements.
Understand GMP-Grade Manufacturing: Gain insights into the company's commitment to quality and consistency.
Engage with the Biopharma PEG Team: Discuss specific project needs and explore potential collaborations.
Biopharma PEG encourages attendees to schedule dedicated meeting times during TIDES USA 2025 to ensure personalized discussions. Please contact sales@biochempeg.com to arrange a meeting or feel free to visit Booth #913 at your convenience.
Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050 / 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Biopharma PEG Scientific Inc. is a leading global provider of high-quality GMP-grade polyethylene glycol (PEG) derivatives, offering a comprehensive catalog of over 4,000 products alongside custom synthesis services. We specialize in supporting critical biopharmaceutical applications such as PEGylation, LNP drug delivery, ADC therapy, PROTAC development, hydrogels, and diagnostics. Committed to quality and innovation, Biopharma PEG partners with researchers and developers worldwide, providing reliable PEG solutions in quantities from milligrams to kilograms to accelerate the advancement of life-changing therapeutics and diagnostics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025 here
News-ID: 3993565 • Views: …
More Releases from Biopharma PEG Scientific Inc
FDA Approval of Vepdegestrant Highlights the Growing Importance of Linker Design …
Watertown, MA - The recent FDA approval of vepdegestrant (VeppanuTM, ARV-471) marks a significant milestone for targeted protein degradation, bringing the first PROTAC therapy into clinical practice for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. Beyond validating the PROTAC modality, this achievement has renewed attention on one of its most critical design elements-the linker.
Unlike conventional small-molecule inhibitors, PROTACs (Proteolysis Targeting Chimeras) eliminate disease-causing proteins by recruiting an…
Biopharma PEG to Present PEG Derivatives at TIDES USA 2026 in Boston
Biopharma PEG will exhibit at TIDES USA 2026 in Boston this May, where the company will introduce its latest portfolio of high-purity PEG derivatives for drug delivery, bioconjugation, and related pharmaceutical research applications.
The event will be held at the Hynes Convention Center in Boston, Massachusetts, USA, from May 11-14, 2026. Biopharma PEG will welcome visitors at Booth 826 to discuss product selection, application needs, and supply support for research and…
Biopharma PEG Offers In-Stock Monodispersed PEGs at Competitive Prices
Biopharma PEG Scientific Inc. announced the availability of a broad range of in-stock monodispersed PEG derivatives at highly competitive prices, supporting researchers working in antibody-drug conjugates (ADCs), nanoparticle and LNP delivery systems, diagnostics, and biomaterials.
Biopharma PEG specializes in PEG derivatives, including monodispersed, polydispersed, and multi-arm PEGs, offered in both GMP and non-GMP grades. By keeping key monodispersed PEGs on the shelf and ready to ship, the company aims to help…
Biopharma PEG Highlights the Critical Role of PEG-Lipid Nanoparticles in RNA The …
Watertown, MA, September 26, 2025 - In the past decade, lipid nanoparticles (LNPs) have emerged as the premier delivery vehicle for RNA-based medicines, powering the success of both siRNA drugs and mRNA vaccines. A key component of these systems is PEG-lipids, specialized polyethylene glycol (PEG) derivatives that stabilize nanoparticles, extend circulation time, and enhance safety.
Why PEG-Lipids Are Essential
RNA molecules are inherently unstable in the bloodstream, where they are rapidly degraded…
More Releases for GMP
IMARC Engineering Enhances GMP Readiness Assessment Through GMP Compliance Audit …
Good Manufacturing Practice compliance in India has moved from a paperwork exercise to a business-critical priority. Regulatory tightening under the revised Schedule M framework has raised the bar for infrastructure, documentation, and quality systems across pharmaceutical, food, and healthcare manufacturing.
A GMP readiness assessment finds the gaps before a regulator, buyer, or certification body does. IMARC Engineering's GMP Compliance Audit Services convert scattered documentation and ad-hoc practices into an audit-ready quality…
Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more…
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp.
This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users…
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials
AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008.
“ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,…
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures.
The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style…
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,…
